No significant differences were found in the SLDH levels depending on gender, tumor location, tumor size, tumor differentiation, Lauren's classification, HER2 status, pathologic T stage (pT), N stage, lymphovascular invasion, perineural invasion, or receipt of adjuvant chemotherapy. This evidence concerns the gene ERBB2 and neoplasm.